pravastatin has been researched along with Acute Confusional Senile Dementia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (88.24) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, R; Craig, D; McGuinness, B; Passmore, P | 2 |
| Anantharamaiah, GM; Cao, D; Garber, DW; Handattu, SP; Kadish, I; Li, L; Monroe, CE; Nayyar, G; Palgunachari, MN; van Groen, T | 1 |
| Albers, JJ; Dong, W; Vuletic, S | 1 |
| Biasibetti, R; Bobermin, L; Gonçalves, CA; Quincozes-Santos, A; Rodrigues, L; Tramontina, AC; Tramontina, F; Wartchow, KM | 1 |
| Lipton, AM; Lutjohann, D; Moore, C; Svetlik, D; Vega, GL; Von Bergmann, K; Weiner, MF | 1 |
| Baskin, F; Fang, X; Hynan, LS; Moore, CB; Rosenberg, RN; Vega, GL; Weiner, M | 1 |
| Ikeda, S; Ishii, K; Matsushima, T; Miya, F; Shoji, S; Tamaoka, A; Tokuda, T | 1 |
| Albers, JJ; Galasko, D; Hazzard, WR; Lee, M; Lee, VM; Leverenz, JB; Li, G; Montine, TJ; Peskind, ER; Petrie, EC; Riekse, RG; Schellenberg, GD; Seubert, P; Vavrek, D; Vuletic, S | 1 |
| Ghribi, O | 1 |
| Blauw, GJ; Bollen, EL; Buckley, BM; Caslake, MJ; Cobbe, SM; Ford, I; Gaw, A; Hyland, M; Jolles, J; Jukema, JW; Kamper, AM; Macfarlane, PW; Murphy, MB; Murray, HM; Packard, CJ; Perry, IJ; Shepherd, J; Stott, DJ; Sweeney, BJ; Twomey, C; Westendorp, RG | 1 |
| Dietschy, JM; Haley, RW | 1 |
| Celesia, GG; Kellman, W; Ruosseau, P; Siegel, G; Wolozin, B | 1 |
| Feinberg, AW | 1 |
| Blauw, GJ; Murphy, MB; Shepherd, J | 1 |
| Bollen, EL; Buckley, BM; Gaw, A | 1 |
| Marx, J | 1 |
2 review(s) available for pravastatin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Statins for the prevention of dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Anticholesteremic Agents; Cognition; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin | 2016 |
Statins for the prevention of dementia.
Topics: Alzheimer Disease; Anticholesteremic Agents; Cognition; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin | 2009 |
3 trial(s) available for pravastatin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Topics: Aged; Alzheimer Disease; Brain; Cholesterol 24-Hydroxylase; Female; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Simvastatin; Steroid Hydroxylases; Treatment Outcome | 2003 |
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Blood Platelets; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Niacin; Pravastatin; Protein Processing, Post-Translational; Simvastatin; Single-Blind Method | 2003 |
Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Brain; Cholesterol; Cholesterol, LDL; F2-Isoprostanes; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Neuroprotective Agents; Peptide Fragments; Pravastatin; Simvastatin; tau Proteins; Triglycerides | 2006 |
12 other study(ies) available for pravastatin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anticholesteremic Agents; Apolipoprotein A-I; Astrocytes; Chemokine CCL2; Cholesterol; Cognition; Disease Models, Animal; Drug Therapy, Combination; Hippocampus; Interleukin-1beta; Male; Maze Learning; Mice; Mice, Transgenic; Microglia; Plaque, Amyloid; Pravastatin; Protease Nexins; Receptors, Cell Surface; Tumor Necrosis Factor-alpha | 2009 |
Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells.
Topics: Alzheimer Disease; Apolipoproteins E; Astrocytes; ATP-Binding Cassette Transporters; Blotting, Western; Cells, Cultured; Electrophoresis; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neurons; Phospholipid Transfer Proteins; Polymerase Chain Reaction; Pravastatin; Simvastatin; tau Proteins | 2009 |
The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neuroprotective Agents; Pravastatin; Rats; Rats, Wistar; Simvastatin; Streptozocin | 2011 |
Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans.
Topics: Adult; Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Apolipoproteins E; Cholesterol; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pravastatin | 2003 |
Preservation of the blood brain barrier integrity may underlie neuroprotective effects of statins in Alzheimer's disease.
Topics: Alzheimer Disease; Blood-Brain Barrier; Brain; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Neuroprotective Agents; Pravastatin; Randomized Controlled Trials as Topic; Simvastatin | 2006 |
Association between apolipoprotein E4 and cognitive decline in elderly adults.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Anticholesteremic Agents; Apolipoprotein E4; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Dementia, Vascular; Female; Follow-Up Studies; Genetic Carrier Screening; Homozygote; Humans; Ireland; Male; Mental Status Schedule; Netherlands; Neuropsychological Tests; Phenotype; Pravastatin; Risk Factors; Scotland; Statistics as Topic; Triglycerides | 2007 |
Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic plaque formation in Alzheimer disease?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anticholesteremic Agents; Apolipoproteins E; Cholesterol; Clinical Trials as Topic; Humans; Hypercholesterolemia; Neurites; Neurofibrillary Tangles; Pravastatin | 2000 |
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome | 2000 |
Statins & Alzheimer's.
Topics: Aged; Alzheimer Disease; Anticholesteremic Agents; Dementia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Middle Aged; Pravastatin | 2000 |
Dementia and statins. PROSPER study group.
Topics: Aged; Alzheimer Disease; Anticholesteremic Agents; Dementia, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Randomized Controlled Trials as Topic | 2001 |
Statin therapy and the prevention of dementia.
Topics: Alzheimer Disease; Anticholesteremic Agents; Dementia, Vascular; Humans; Lovastatin; Pravastatin; Randomized Controlled Trials as Topic | 2001 |
Alzheimer's disease. Bad for the heart, bad for the mind?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Anticholesteremic Agents; Apolipoprotein E4; Apolipoproteins E; Aspartic Acid Endopeptidases; Brain; Cells, Cultured; Cholesterol; Clinical Trials as Topic; Endopeptidases; Humans; Membrane Microdomains; Neurons; Pravastatin; Sterol O-Acyltransferase | 2001 |